SPDR Barclays Long Term Corporate Bond (SPLB)
SPLB price chart
SPLB fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $4 a year in fund costs, taken out of the fund's assets.
Income: distributions
SPLB top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | State Street Global Advisors | 2.31% |
| 2 | ANHEUSER-BUSCH CO/INBEV | 0.35% |
| 3 | CVS HEALTH CORP | 0.34% |
| 4 | AMAZON.COM INC | 0.31% |
| 5 | META PLATFORMS INC | 0.28% |
| 6 | CHARTER COMM OPT LLC/CAP | 0.28% |
| 7 | META PLATFORMS INC | 0.27% |
| 8 | BROADCOM INC | 0.26% |
| 9 | META PLATFORMS INC | 0.26% |
| 10 | PFIZER INVESTMENT ENTER | 0.26% |
Similar Bond ETFs
TBIL Us Treasury 3 Month Bill0.15% fee · +3.7% 1y SCMB Schwab Municipal Bond0.03% fee · −1.6% 1y USIG iShares Broad USD Investment G...0.04% fee · −1.3% 1y MUNI PIMCO Intermediate Municipal B...0.35% fee · −0.3% 1y SCHP Schwab U.S. TIPS0.03% fee · −1.0% 1y CGMU Capital Group Municipal Income0.27% fee · −0.0% 1y All bond ETFs →SPLB: frequently asked questions
What is SPLB?
SPLB is the SPDR Barclays Long Term Corporate Bond ETF, issued by State Street (SPDR), listed on NYSE ARCA. By our rules it is classed as "Bond". Its latest SEC filing lists 2,951 holdings.
What is the expense ratio of SPLB?
SPLB charges 0.04% a year, according to its prospectus filed with the SEC on 24 Oct 2025. On $10,000 that is about $4 a year in fund costs.
Does SPLB pay dividends?
Yes. SPLB paid 1.21 per share over the last 12 months, monthly, a trailing yield of 5.73% on today's price. The latest ex-dividend date was 1 Oct 2026.
What does SPLB hold?
The largest holdings in the latest SEC filing are State Street Global Advisors (2.3%), ANHEUSER-BUSCH CO/INBEV (0.4%), CVS HEALTH CORP (0.3%). The top 10 together make up 4.9% of the fund.
How has SPLB performed?
Total return including distributions to 22 Oct 2026: 1 year −5.4%, 3 years +6.9% a year, 5 years −3.1% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.